Abu Dhabi Investment Authority Invests $200 Million in Indian MedTech Company Meril
核心洞察
Abu Dhabi Investment Authority (搜索) (ADIA) will acquire a 3% stake in Indian medical device company Micro Life Sciences (搜索) (Meril (搜索)) for $200 million, valuing the company at $6.6 billion.
Meril (搜索) specializes in clinically advanced medical technology solutions across cardiovascular, structural heart, orthopedics, endo-surgery, in-vitro diagnostics, and surgical robotics.
The investment will enable Meril (搜索) to accelerate growth, attract world-class talent, and strengthen clinical research efforts to improve healthcare solutions globally.
Abu Dhabi Investment Authority (搜索) (ADIA) has entered into definitive agreements to invest $200 million for a 3% stake in Micro Life Sciences (搜索) Private Limited (Meril (搜索)), one of India's leading medical device companies. The investment values Meril at an enterprise value of $6.6 billion and is subject to regulatory approval by the Competition Commission of India (搜索) (CCI).
Strategic Investment in Medical Technology Innovation
Founded by the Bilakhia Group (搜索), Meril (搜索) is a global innovator in medical technology with a focus on clinically advanced solutions across multiple specialties, including cardiovascular, structural heart, orthopedics, endo-surgery, in-vitro diagnostics, and surgical robotics. The company operates from its headquarters in Vapi, Gujarat, where it maintains state-of-the-art, vertically integrated, and globally certified manufacturing and R&D facilities across a 100-acre sustainable MedTech campus.
Post this investment, Meril (搜索) will be backed by two globally recognized investors: ADIA and Warburg Pincus (搜索), strengthening its position in the global medical technology market.
Global Reach and Operational Scale
Meril (搜索) employs more than 13,000 people and has over 35 global subsidiaries, serving healthcare systems in around 150 countries. The company has built an in-house global R&D ecosystem with a portfolio of 200+ technology platforms. Through its 12+ global training academies, Meril empowers over 10,000 healthcare professionals annually.
"This investment by ADIA reinforces confidence in Meril (搜索)'s long-term vision and global ambitions," said Sanjeev Bhatt, Senior Vice President - Strategy at Meril. "This investment will enable us to accelerate growth, attract world-class talent, and further strengthen our R&D and clinical research efforts as we work towards improving the quality of human life through advanced healthcare solutions."
About the Investor
Established in 1976, the Abu Dhabi Investment Authority (搜索) is a globally diversified investment institution that prudently invests funds on behalf of the Abu Dhabi government through a strategy focused on long-term value creation. The investment in Meril (搜索) represents ADIA's continued commitment to supporting innovative healthcare companies with strong growth potential and global reach.